Annual Accounts Receivable
N/A
31 December 2023
Summary:
Spyre Therapeutics annual accounts receivable is not available.SYRE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
Spyre Therapeutics quarterly accounts receivable is not available.SYRE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
SYRE Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time |
Spyre Therapeutics Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $21.50 M(+787.7%) |
Sept 2018 | - | $2.42 M(-43.4%) |
June 2018 | - | $4.28 M(+26.9%) |
Mar 2018 | - | $3.37 M(+9.6%) |
Dec 2017 | $3.08 M | $3.08 M(+25.5%) |
Sept 2017 | - | $2.45 M(+102.1%) |
June 2017 | - | $1.21 M(+23.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2017 | - | $981.00 K(-19.3%) |
Dec 2016 | $1.22 M(-28.4%) | $1.22 M(-22.7%) |
Sept 2016 | - | $1.57 M(-3.3%) |
June 2016 | - | $1.63 M(+0.4%) |
Mar 2016 | - | $1.62 M(-4.7%) |
Dec 2015 | $1.70 M | $1.70 M(-59.9%) |
Sept 2015 | - | $4.24 M(+23.6%) |
June 2015 | - | $3.43 M |
FAQ
- What is the all time high annual accounts receivable for Spyre Therapeutics?
- What is the all time high quarterly accounts receivable for Spyre Therapeutics?
What is the all time high annual accounts receivable for Spyre Therapeutics?
Spyre Therapeutics all-time high annual accounts receivable is $3.08 M
What is the all time high quarterly accounts receivable for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly accounts receivable is $21.50 M